GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Cash Payments

Sensorion (XPAR:ALSEN) Cash Payments


View and export this data going back to 2015. Start your Free Trial

What is Sensorion Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.


Sensorion (XPAR:ALSEN) Business Description

Traded in Other Exchanges
Address
375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company dedicated to the development of therapies to restore, treat and prevent hearing loss. The company's product is in phase 2 clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies.